-

IFF Announces Global Price Increases Across All Divisions

NEW YORK--(BUSINESS WIRE)--IFF (NYSE: IFF) today announced that it is implementing broad-based pricing actions across all four divisions – Nourish, Health & Biosciences, Scent, and Pharma Solutions. The immediate need for these price increases is driven by the continued and significant escalation of raw material, energy and logistics costs as a result of the current geopolitical climate.

Pricing actions will vary by business and be driven by specific product cost increases. These actions will include more frequent pricing reviews – dynamic pricing – to ensure IFF product reflects current market realities.

Actions on specific accounts will be communicated by the respective account managers.

Welcome to IFF
At IFF (NYSE: IFF), an industry leader in food, beverage, health, biosciences and scent, science and creativity meet to create essential solutions for a better world – from global icons to unexpected innovations and experiences. With the beauty of art and the precision of science, we are an international collective of thinkers who partners with customers to bring scents, tastes, experiences, ingredients and solutions for products the world craves. Together, we will do more good for people and planet. Learn more at iff.com, Twitter, Facebook, Instagram, and LinkedIn.

© 2022 by International Flavors & Fragrances Inc. IFF is a Registered Trademark. All Rights Reserved

Contacts

Michael DeVeau
Chief Investor Relations & Communications Officer
212.708.7164
Michael.DeVeau@iff.com

Industry:

International Flavors & Fragrances Inc.

NYSE:IFF
Release Versions
English

Contacts

Michael DeVeau
Chief Investor Relations & Communications Officer
212.708.7164
Michael.DeVeau@iff.com

More News From International Flavors & Fragrances Inc.

IFF Secures First Heart Health Claim for Soy Protein in Australia and New Zealand

ST. LOUIS--(BUSINESS WIRE)--IFF (NYSE: IFF), a global leader in flavors, fragrances, food ingredients and health & biosciences announced today that a new heart health claim for isolated soy protein has been accepted by the Food Standards Australia New Zealand (FSANZ). The approval enables food and beverage manufacturers in Australia and New Zealand to link soy protein consumption with healthy blood cholesterol levels. “For decades, IFF has invested in the science behind soy protein and its...

IFF Expands Latin American Footprint With New Enzyme Hub, Brazil Application Lab

BUENOS AIRES, Argentina & SÃO PAULO--(BUSINESS WIRE)--IFF (NYSE: IFF) — a global leader in flavors, fragrances, food ingredients and health & biosciences — is enhancing regional production and innovation capabilities to better support the continued growth of its Health & Biosciences (H&B) business in Latin America, one of the fastest-growing markets for the company. The effort includes the transformation of the Arroyito site in Argentina into IFF’s first full fermentation‑based enzy...

IFF Declares Dividend for First Quarter 2026

NEW YORK--(BUSINESS WIRE)--IFF (NYSE: IFF) announced that its Board of Directors has declared a regular quarterly cash dividend of $0.40 per share of its common stock, payable on April 10, 2026 to shareholders of record as of March 20, 2026. Welcome to IFF At IFF (NYSE: IFF), we make joy through science, creativity and heart. As the global leader in flavors, fragrances, food ingredients, health and biosciences, we deliver groundbreaking, sustainable innovations that elevate everyday products—ad...
Back to Newsroom